Alaunos Therapeutics Inc (TCRT) NPV
Sell:$2.70Buy:$3.14
$0.07
(2.40%)
- This stock can be held in a
Stocks and Shares ISA$0.07
(2.40%)$0.07
(2.40%)Company Information
About this company
Alaunos Therapeutics, Inc. is a pre-clinical obesity and metabolic disorder and clinical-stage oncology-focused cell therapy company. The Company focuses on developing small molecules that are expected to be efficacious against obesity and other metabolic disorders. The Company is engaged in developing novel small molecule-based obesity therapeutics. The Company’s operations consist primarily of conducting research and development and raising capital to fund those efforts. The Company has not generated any revenues.
Key people
Key facts
- EPICTCRT
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINUS98973P3091
- Market cap$5.05m
- Employees1
- Shares in issue1.64m
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.